Want to join the conversation?
Niche pharmaceutical company $AKRX posted 4Q15 net income of $32.78MM or $0.27 per diluted share vs. $17.98MM or $0.16 per diluted share in 4Q14. Revenues rose 38% to $0.28Bil vs. 4Q14, helped by higher gross profit results of $174.43MM. Total operating income also rose to $64.47MM during the quarter.
Any idea why some investors are happy about the disastrous $UA results??
Wow! GM killed it with earnings today! Did not expect this after $F gave the feeling it will eclipse the Chevy maker completely!
Oil rebound starting to show up in energy stocks. $XOM $CVX
I have a feeling "CLOUDy" days are ahead, with $AMZN leading the pack.
$AAL is giving pay hikes to its employees but investors are sulking.